EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long‐term impact of gastropexy on use of acid‐reducing medication, second operations for gastroesophageal reflux and subjective reflux symptoms after sleeve gastrectomy

Tone Nygaard Flølo iD, Alexander Fosså iD, Jonas Ingolf Petersson Nedkvitne iD, Jo Erling Riise Waage iD, Magne Rekdal iD, Simon Nitter Dankel iD, Johan Fernø iD, Gunnar Mellgren iD, Bjørn Gunnar Nedrebø iD

Clinical Obesity · 2023

DOI: 10.1111/cob.12618 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Obesity, 2023. Verfasst von Tone Nygaard Flølo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, Department of Nursing and Health Promotion, Oslo Metropolitan University, Oslo, Norway. Hauptthemen laut MEDLINE: Gastroesophageal Reflux, Obesity, Morbid, Laparoscopy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We investigated whether adding gastropexy to sleeve gastrectomy (SG) reduced gastroesophageal reflux disease (GERD) in patients operated for severe obesity, assessed mainly by use of anti‐reflux medication (ARM) and second operations due to GERD worsening. In a prospective non‐randomized study, patients undergoing SG at two Norwegian hospitals were included from 2011 to 2015 and followed for 7 years. GERD was defined by regular use of ARM, and epigastric pain and heartburn were measured by the Rome II questionnaire. Gastropexy was done by suturing the gastrocolic ligament to the staple line. Patients undergoing SG only, mainly before gastropexia was introduced in 2013, were compared to those with additional gastropexy from 2013 onwards. Of 376 included patients (75% females, mean age 42.6 years and BMI 42.9 kg/m 2 ), 350 (93%) and 232 (62%) were available for evaluation after 1 and 7 years, respectively. Baseline characteristics in the no‐gastropexy ( n = 235) and gastropexy groups ( n = 141) were similar. In patients without ARM use before surgery, the use increased and in those that used ARM at baseline, the proportion decreased, with no difference in the no‐gastropexy and gastropexy groups. With a combined endpoint of ARM use and/or second operation for GERD, there was no difference during follow‐up between the two groups. With time, adding gastropexy did not reduce symptoms of GERD significantly. In this population, adding gastropexy to SG did not reduce use of ARM and/or second operation for uncontrolled GERD, epigastric pain or heartburn during the first 7 postoperative years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastroesophageal RefluxObesity, MorbidLaparoscopyFemaleHumansAdultMaleHeartburnProspective StudiesGastrectomyPainRetrospective Studies

Stichwörter der Autor:innen

Sleeve gastrectomygastroesophageal reflux diseasegastropexy

Autor:innen und Institutionen

  • Faculty of Health Sciences, Department of Nursing and Health Promotion, Oslo Metropolitan University, Oslo, Norway.
  • Voss Hospital, Haukeland University Hospital, Voss, Norway.
  • Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • KG Jebsen Centre for B-Cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
  • DIPS AS, Bergen, Norway.
  • Department of Clinical Science, University of Bergen, Bergen, Norway.

ORCID-Profile: Tone Nygaard Flølo, Alexander Fosså, Jonas Ingolf Petersson Nedkvitne, Jo Erling Riise Waage, Magne Rekdal, Simon Nitter Dankel, Johan Fernø, Gunnar Mellgren, Bjørn Gunnar Nedrebø

Zitieren

APA

Flølo, T. N., Fosså, A., Nedkvitne, J. I. P., Waage, J. E. R., Rekdal, M., Dankel, S. N., Fernø, J., Mellgren, G., & Nedrebø, B. G. (2023). Long‐term impact of gastropexy on use of acid‐reducing medication, second operations for gastroesophageal reflux and subjective reflux symptoms after sleeve gastrectomy. Clinical Obesity. https://doi.org/10.1111/cob.12618

Vancouver

Flølo TN, Fosså A, Nedkvitne JIP, Waage JER, Rekdal M, Dankel SN, et al. Long‐term impact of gastropexy on use of acid‐reducing medication, second operations for gastroesophageal reflux and subjective reflux symptoms after sleeve gastrectomy. Clinical Obesity. 2023. doi:10.1111/cob.12618

BibTeX
@article{Fllo2023,
  author = {Flølo, Tone Nygaard and Fosså, Alexander and Nedkvitne, Jonas Ingolf Petersson and Waage, Jo Erling Riise and Rekdal, Magne and Dankel, Simon Nitter and Fernø, Johan and Mellgren, Gunnar and Nedrebø, Bjørn Gunnar},
  title = {Long‐term impact of gastropexy on use of acid‐reducing medication, second operations for gastroesophageal reflux and subjective reflux symptoms after sleeve gastrectomy},
  journal = {Clinical Obesity},
  year = {2023},
  doi = {10.1111/cob.12618}
}
Kostenlos starten →